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ALC – absolute lymphocyte count 
APACHE II – Acute Physiology and Chronic Health Evaluation 
ARDS – acute respiratory distress syndrome 
AUROC – area under the receiver operating curve 
CCI – Charlson Comorbidity Index 
CI – confidence interval 
CK – creatinine kinase 
CSC – crisis standard of care 
EHR – electronic health record 
HDC – Health Data Compass 
ICU – intensive care unit 
IT – information technology 
LDH – lactate dehydrogenase 
SAPS II – Simplified Acute Physiology Score 
SOFA – Sequential Organ Failure Assessment 
PSI – Pneumonia Severity Index 
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Take Home Points  
Study Question: Can we improve upon the SOFA score for real-time mortality prediction during the 
COVID-19 pandemic by leveraging electronic health record (EHR) data? 
Results: We rapidly developed and implemented a novel yet SOFA-anchored mortality model across 12 
hospitals and conducted a prospective cohort study of 27,296 adult hospitalizations, 1,358 (5.0%) of 
which were positive for SARS-CoV-2. The Charlson Comorbidity Index and SOFA scores predicted all-
cause mortality with AUROCs of 0.72 and 0.90, respectively. Our novel score predicted mortality with 
AUROC 0.94.  
Interpretation: A novel EHR-based mortality score can be rapidly implemented to better predict patient 
outcomes during an evolving pandemic. 
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Abstract: (299/300 words) 
Background: The SARS-CoV-2 virus has infected millions of people, overwhelming critical care resources 
in some regions. Many plans for rationing critical care resources during crises are based on the 
Sequential Organ Failure Assessment (SOFA) score. The COVID-19 pandemic created an emergent need 
to develop and validate a novel electronic health record (EHR)-computable tool to predict mortality. 
Research Questions: To rapidly develop, validate, and implement a novel real-time mortality score for 
the COVID-19 pandemic that improves upon SOFA. 
Study Design and Methods: We conducted a prospective cohort study of a regional health system with 
12 hospitals in Colorado between March 2020 and July 2020. All patients >14 years old hospitalized 
during the study period without a do not resuscitate order were included. Patients were stratified by the 
diagnosis of COVID-19. From this cohort, we developed and validated a model using stacked 
generalization to predict mortality using data widely available in the EHR by combining five previously 
validated scores and additional novel variables reported to be associated with COVID-19-specific 
mortality.  We compared the area under the receiver operator curve (AUROC) for the new model to the 
SOFA score and the Charlson Comorbidity Index. 
Results:  We prospectively analyzed 27,296 encounters, of which 1,358 (5.0%) were positive for SARS-
CoV-2, 4,494 (16.5%) included intensive care unit (ICU)-level care, 1,480 (5.4%) included invasive 
mechanical ventilation, and 717 (2.6%) ended in death. The Charlson Comorbidity Index and SOFA 
scores predicted overall mortality with an AUROC of 0.72 and 0.90, respectively. Our novel score 
predicted overall mortality with AUROC 0.94. In the subset of patients with COVID-19, we predicted 
mortality with AUROC 0.90, whereas SOFA had AUROC of 0.85. 
Interpretation: We developed and validated an accurate, in-hospital mortality prediction score in a live 
EHR for automatic and continuous calculation using a novel model, that improved upon SOFA. 
Key Words: Crisis Triage, Mortality Prediction, COVID-19, Machine Learning 
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The SARS-CoV-2 virus has infected >70 million and killed >1.5 million people in the year since its 
origination (December 2019).
1
 The resulting pandemic has overwhelmed some regions’ health care 
systems and critical care resources, forcing the medical community to confront the possibility of 
rationing resources.
2,3
 In the United States, critical care triage guidance in the setting of resource 
scarcity is produced at the state-level through Crisis Standards of Care (CSC) protocols.
4,5
 These 
protocols attempt the difficult task of ethically allocating scarce resources to individuals most likely to 
benefit, with the aim of saving the most lives.
6–8
 To accomplish this, CSC protocols use organ dysfunction 
scores and chronic comorbidity scores to assess patient survivability. Ideally, scoring would avoid 
systematic bias and be generalizable, accurate, flexible to circumstance, and computable within 
electronic health record (EHR) systems with data collected in real-time.
9
 
At the foundation of most CSC protocols is the Sequential Organ Failure Assessment (SOFA) score.
10,11
 
SOFA and other acuity scores, e.g., SAPSII and APACHE, are well-validated but have significant 
limitations. They were developed over 20 years ago before widespread electronic health records (EHRs), 
are rigid regarding context, and were designed to measure severity of illness and predict mortality based 
a few data points.
12–17
 Although SOFA predicts mortality from influenza pneumonia poorly, it was 
operationalized for use in patients with COVID-19.
11,18,19
  Optimizing the accuracy of mortality 
predictions is critical for medical triage because the decision to withhold or withdraw of life-sustaining 
therapies is heavily influenced by a single score in many states’ CSC protocols.
11
 
The COVID-19 pandemic created an emergent need for a novel, accurate, and context-sensitive EHR-
computable tool to predict mortality in hospitalized patients with and without COVID-19. Because 
developing a new score can take years, a predictive model must rely on well-validated scores, only 
adding new inputs to improve performance. Stacked generalization provides a solution.
20
 A stacked 
model is built upon one of or more baseline model (e.g. SOFA) and incorporates additional models only 
when they improve prediction.
21
  
We rapidly developed and validated a novel mortality score for triage of all hospitalized patient during 
the COVID-19 pandemic by stacking SOFA, qSOFA, a widely used pneumonia mortality score, an acute 
respiratory distress syndrome (ARDS) mortality model, and a comorbidity score.
12,22–25
 We then 
integrated recently reported predictors that may reflect COVID-19 pathophysiology. To test the novel 
model, we conducted a prospective cohort study of acutely ill adults with and without COVID-19 
disease.  
 
Study Design and Methods: 
We began by developing the novel mortality score using a multi-hospital retrospective cohort of 82,087 
patient encounters (Figure 1 and Appendix A). We then conducted a prospective cohort study to 
validate the novel mortality score in patients with and without COVID-19. Our work was anchored by 
four goals. First, to use SOFA as a baseline and address its limitations through stacked generalization, 
adding other models with the potential to improve robustness and predictive performance. Second, to 
integrate and test potential COVID-19-specific predictors. Third, to rapidly deploy the new model in a 
live EHR across a 12-hospital system that serves more than 1.9 million patients. Fourth, to validate 
model performance prospectively. The Colorado Multiple Institutional Review Board approved this study 
(#20-0995). 
Workflow and Model Deployment 
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Rapid development and implementation of a new score requires a full clinical and informatics pipeline 
including skilled data warehousing, data wrangling, machine learning, health system information 
technology (IT), and clinical and ethics personnel working in sync.
26–28
 All data flowed to the study team 
from UCHealth’s Epic instance through Health Data Compass (HDC), the enterprise data warehouse for 
the University of Colorado Anschutz Medical Campus (Figure 1).
29
 HDC is a multi-institutional data 
warehouse that links inpatient and outpatient electronic medical data, state-level all-payer claims data, 
and the Colorado Death Registry. The creation of data sets and models required identification of the 
correct data elements in both operational EHR and warehoused data tables to ensure accuracy and 
robustness. Rapid development, validation, and deployment of a novel model within the real-time EHR 
required close collaboration among three teams: 1) a data science team, 2) a clinical data warehouse 
team, and 3) a clinical informatics operations team (Appendix A).  
This study design is consistent with recent learning health system studies.
30
 Because of the rapidly 
evolving pandemic, we built a data pipeline for the stacked mortality model to update as new data were 
captured from the EHR. We originally developed, validated and deployed the model using estimates 
from retrospective data, while simultaneously building technical capacity to transition to a model 
estimated on prospective data. The time from conception to deployment of the new model across the 
hospital system was one month. 
Prospective Cohort 
The prospective cohort included all encounters of patients >14 years old hospitalized at any of 
UCHealth’s 12 acute care hospitals between March 15, 2020 (the date UCHealth halted elective 
procedures) through July 2020.  Because CSC protocols apply to all hospitalized patients during a crisis, 
we included all inpatients regardless of level of care or COVID-19 status. We excluded encounters with a 
do not attempt resuscitation order placed within 12 hours of admission, patients who were still 
admitted, and encounters longer than  30 days. 
Model Methodology 
We developed a model using stacked generalization to predict mortality.
20,31,32
 A stacked regression 
model takes other component models as covariates and estimates weights in accordance with their 
predictive power.
31
 We chose ridge regularized logistic regression as the top-level model to limit 
overfitting and to address correlation between the component models.
21
 Stacking allows for robust, 
accurate, and interpretable evaluation of the underlying models.
32
 Moreover, the stacked model never 
performs worse than the most accurate component model (see Appendix A).
33
  
The stacked regression takes six logistic regression mortality models as covariates. Four are validated 
organ dysfunction or pneumonia/ARDS mortality prediction tools, a fifth is a comorbidity score, and a 
sixth is novel and COVID-specific. These models include: (1) SOFA, (2) qSOFA, (3) the CURB-65 adult 
pneumonia mortality score, (4) a modified version of an ARDS mortality model, and (5) a Charlson 
Comorbidity Index (Appendix A).
12,14,23–25
 The ARDS mortality model was attenuated to include the 
subset of predictors reliably available in structured form in live EHRs. The sixth model includes variables 
hypothesized and reported to be associated with COVID-19-specific disease severity or mortality.  This 
includes, for example, D-dimer, lactate dehydrogenase (LDH), absolute lymphocyte count (ALC), and 
creatinine kinase (CK, Appendix A).
34–36
 Variables such as gender, race, or disability status were not 
included in any models. 
Real-time predicted mortality 
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Probability of mortality varies over the hospital course (Appendix B) and can be estimated at any time 
during the hospitalization. Thus, to estimate and validate model parameters, we selected a single time 
point to make a prediction – when the SOFA score reached its maximum for the encounter. 
Operationally, this framework allows for real-time mortality prediction under the assumption that the 
current measured state of the patient is the worst state the patient will experience. While this 
assumption will not be correct for all moments in time, it effectively underestimates the patient’s 
overall mortality, thus reducing the chance for premature limitation of critical care resources if used for 
triage decisions.  
Model Training, Evaluation, and Validation: 
We divided the retrospective data 40%-40%-20% for estimating the baseline logistic regression models, 
estimating the stacked model, and evaluating the stacked model, respectively. We estimated the 
stacked models with regularized (ridge) logistic regression and used 3-fold cross-validation to select a 
regularization parameter. The final stacked model was evaluated using empirical-bootstrap-estimated 
confidence intervals (CIs) and a primary metric of area under the receiver operator curve (AUROC). We 
validated the stacked model using the prospective cohort and the AUROC.  
We chose AUROC as the accuracy metric because the primary goal of the mortality score was to 
generate a ranked list of patients to inform the allocation of scare resources. The AUROC is an estimate 
of the probability of correctly ranking a case compared to a non-case. We also estimated other accuracy 
metrics including positive predictive value, sensitivity, specificity, accuracy, and F1-measure (see 
Appendix B, eFigure1).  
To evaluate the impact of COVID-19 on mortality prediction, we retrained the model using the same 
training strategy but limited training data to patients with COVID-19. Specifically, we divided the cohort 
of patients with COVID-19 40%-40%-20% for estimating the baseline logistic regression models, 
estimating the stacked model, and evaluating the stacked model, respectively.Ethical Considerations 
This novel score was developed with the purpose of optimizing mortality prediction for crisis triage. 
Consequently, the score parameters needed to fall with the ethical framework developed for crisis 
triage. Briefly, in catastrophic circumstances the goal of a resource allocation processes should be to 
provide the most benefit to as many people as possible, and to do so in ways that sustain social 
cohesion and trust in the healthcare system. To maintain trust, recommendations for rationing of 
resources must be made prospectively, transparently and consistently across the institution and region, 
and by decision-makers independent of the care team. Moreover, any decision to ration resources must 
embrace a commitment to fairness and a proscription against rationing based on non-clinical factors 
such as race, gender, sexual orientation, disability, religious beliefs, citizenship status, or “VIP,” 
socioeconomic,or insurance status.
37–40
 Consequently, factors such a race were excluded from score 
development, even if they had the potential to improve accuracy. 
Results: 
Cohort Characteristics and Hospital Course: 
The prospective cohort included a total of 28,538 encounters between March 15
th
, 2020 and July 2020. 
Of these, 1,148 (4.0%) were excluded because the patient remained in hospital at the time of data 
censoring: in-hospital survival could not be assessed. Additionally, we excluded 70 and 24 encounters 
respectivelydue to active DNR and encounter length>30 days. Of the remaining 27,296 encounters, 
1,358 (5.0%) were positive for SARS-CoV-2, 4,494 (16.5%) included intensive care unit (ICU)-level care, 
1,480 (5.4%) included invasive mechanical ventilation, and 717 (2.6%) died during the hospitalization. Of 
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the 717 patients who received mechanical ventilation, 408 (27.6%) died. Additional demographics are in 
Table 1, eTable 1, and eTable 2. 
Of the 1,358 encounters positive for COVID-19, 407 (30.0%) received ICU-level care, 239 (17.6%) were 
intubated, and 166 (12.2%) patients died. Of the 239 patients requiring mechanical ventilation, 83 
(34.7%) died. 
Compared to patients without COVID-19, patients with COVID-19 were more likely to be male (55.6% vs 
42.0%, p<0.001), be Hispanic (44.4% vs 14.6%, p<0.001), receive ICU-level care (30.0% vs 15.8%, 
p<0.001), be intubated (17.6% vs 4.8%, p<0.001), have a longer duration of mechanical ventilation (8.7 
days vs 3.0 days, p<0.001), a longer hospital length of stay (7.6 days vs 4.3 days, p<0.001), and not 
survive (12.2% vs 2.1%, p<0.001). Patients with COVID-19 had higher SOFA and CURB-65 scores and LDH, 
ferritin, and D-dimer levels than patients without COVID-19 (all p<0.05, Table 2). Mean troponin levels 
were lower in patients with COVID-19 compared to patients without COVID-19 (p=0.002, Table 2). 
However, absolute lymphocyte count and creatinine kinase levels were not dissimilar between groups 
(all p>0.05, Table 2). 
Point-Wise Mortality Estimates: 
When validating mortality models in the prospective cohort, the individual component models predicted 
point-wise mortality (estimates of mortality risk ranging from 1-99%) with AUROCs ranging from 0.72 
(Charlson Comorbidity Index) to 0.90 (SOFA) (Table 3). The stacked model predicted point-wise mortality 
better than any individual model: AUROC 0.94 (Figure 2). Most prospective encounters (95.7%) had 
predicted point-wise mortalities less than 10%. Within this group, observed mortality was only 1.0%, 
suggesting that the stacked model accurately identifies patients with low mortality (eTable 3). 
In patients with COVID-19, the AUROC for SOFA, CURB-65, the Charlson Comorbidity Index, and novel 
variables was 0.85, 0.90, 0.75, and 0.91 respectively. In this subset of patients, the stacked model 
predicted mortality with an AUROC of 0.90. In both analyses, the stacked model predicted mortality with 
narrowest 95% confidence intervals at the extremes of predicted mortality (eFigure 2). Even at 
moderate predicted mortalities, 95% confidence intervals were generally narrower than ten percentage 
points. Additional results including precision, recall, and time-integrated estimates of mortality are 
reported in Appendix B, eFigure 1. 
When trained with retrospective data and evaluated on patients with COVID-19, the novel model 
outperformed the stacked model (AUROCs of 0.91 and 0.90, respectively). However, re-training the 
stacked model only on patients with COVID-19 improved its COVID-19-specific AUROC to 0.95 (Appendix 
B). The stacked model outperformed all other models for patients with COVID-19. This highlights the 
importance of flexible modeling constructs and suggests that patients with COVID-19 have predictors of 
mortality that differ from average patients.  
Discussion: 
We developed a new, accurate mortality prediction score that is adaptable to different diseases and 
settings. Improving upon SOFA and the Charlson Comorbidity Index to predict mortality, our score 
allows more accurate and granular ranking of patients likely to benefit from intensive care. We rapidly 
deployed the novel score in our EHR during the COVID-19 pandemic for potential real-time use in 
making triage decisions. We demonstrated that reliability was maintained in a prospective cohort of 
patients with and without COVID-19. Fortunately, we have not needed to use these scores for triage, but 
our development process forges a new path for leveraging EHRs, clinical expertise, and machine learning 
to provide real time, situation-critical clinical decision support. 
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This paper adds significantly to the literature regarding CSC and ethically allocating scarce medical 
resources. Like ours, most other scoring systems are based on the SOFA score, which was developed 20 
years ago with simplicity and not triage in mind. SOFA predicted influenza H1N1 mortality poorly.
18,19
 
Others have attempted to build novel scores that are simple and accurate.
6,7
 Our work builds on recent 
reports demonstrating in patients with COVID-19 that SOFA, CURB-65, PSI, APACHE II, and novel, COVID-
specific COVID-GRAM scores predict mortality well: AUROC 0.87, 0.84-0.85, 0.87, 0.96, and 0.78-0.88 
respectively.
41–44
 Although APACHE II out-performs other scores, it includes data that is not easily 
extracted from an EHR in real-time. By stacking multiple models and using data extracted in real-time 
from the EHR, we demonstrate similar AUROC (0.94) in a large prospective cohort of patients on whom 
a CSC-based triage plan would operate: those with and without COVID-19. Finally, CSC protocols have 
collapsed SOFA scores to rank patients in just a few categories, reflecting the difficulty of knowing when 
SOFA scores are sufficiently different to make a meaningful difference for triage. Our approach 
generates 1-99% risk of mortality and the ability to statistically differentiate between patients (or 
determine statistical ties) by calculating 95% CI for each score.  
Our stacked model’s ability to predict mortality is tailored to our patient population in Colorado. This is 
important given the varied experiences with COVID-19. Our in-hospital (12% versus 21%) and ventilator 
mortality rates (35% versus 88%) were substantially lower than a New York cohort.
45
  Our mortality rates 
approach those expected for moderate-severe ARDS.
46,47
 There are potentially many explanations for 
these differences, including younger age, difference in comorbidities, differences in therapeutic 
interventions, and learning from the experience of earlier effected areas. Moreover, the utilization of 
ICU level of care and mechanical ventilation varies widely across the world: in New York, 14.2% of 
patients were treated in an ICU and 12.2% of patient received mechanical ventilation. In contrast, in a 
cohort of patients in China, 50.6% of patients were admitted to an ICU and 42.2% received mechanical 
ventilation.
35,36,41
 Such differences may affect the predictive characteristics of a mortality score. 
Moreover, we found that patients with COVID-19 have unique characteristics and may benefit from 
specific mortality prediction models. Thus, utilizing EHR data streams allows for flexibility to add 
additional components and retrain the stacked model as new knowledge and clinical experience 
accumulates. Importantly for generalization, the model can be tuned in real-time to other local patient 
populations and disease characteristics. 
Several aspects of the informatics infrastructure and workflow are important. First, such a rapid 
development process would have been impossible without a robust data warehouse staffed by experts 
with deep knowledge of EHR data and common clinical data models. The availability of high-quality data 
is known to be among the largest challenges in clinical applications of machine learning.
48
 Second, our 
data science team was in place and had substantial shared experience with data from the health system. 
It would be extremely challenging to either rapidly hire or outsource the necessary expertise during a 
pandemic. Third, our data science team already had access to highly capable cloud-based and on-
premises HIPAA-compliant computational environments. Establishing the processes and controls for 
such an environment takes time and expert human resources; our campus had already made those 
investments. Fourth, our multidisciplinary team included leadership, a variety of potential end-users, 
and experts from ethics, clinical informatics, machine learning, and clinical care.
26
 This diversity critically 
grounded the project in ethical principles and pragmatic clinical realties and allowed us to quickly iterate 
to a practical, implementable, and interpretable model. Because of urgent operational needs, we also 
had full institutional and regulatory support. Finally, we evaluated the model prospectively, an 
important gold-standard not often met by new machine learning-based informatic tools.
26
 Of note, 
there are many reports in the literature describing development of predictive models using EHR data, 
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but very few reports of the implementation of those models in a live EHR for clinical use.  In this case, 
the total elapsed time from including data extraction, model construction, implementation, and 
deployment within the EHR across the 12 UCHealth hospitals was 1 month, illustrating the potential 
capacity for novel predictive model development. Now that we have demonstrated a workflow to 
rapidly develop new informatics tools in our health system, we anticipate that many other tools will 
follow.  
This manuscript has several limitations. First, all scores are calculated from EHR data. While this allows 
for real-time score calculation, it introduces the possibility of artifactual data skewing mortality 
prediction. This was partially addressed by placing acceptable ranges on physiologic variables (see 
Appendix A). Second, missing data or data collected at different time intervals is inherent in the analysis 
of EHR data. To overcome this, we developed a system of imputation and last known value carry 
forward (see Appendix A). Such assumptions may introduce systematic and unmeasured bias but are 
unavoidable operationally. Third, more sophisticated machine learning techniques—e.g., Gaussian 
process regressions—may allow for more accurate mortality predictions.
49
 However, we chose methods 
that were robustly estimable and would allow for transparent interpretation of underlying model 
contributions to the overall score. Fourth, in-hospital mortality may not be the optimal metric to make 
triage decisions. One-year mortality may be a better metric but, given the desire to validate a mortality 
predictor quickly, longer-term outcomes were not available. Fifth, our data and patient population are 
specific to Colorado and results may differ geographically. Finally, some clinical indicators of illness 
severity were not included in the models, e.g. prone positioning, continuous renal replacement therapy, 
and radiographic results. These data may improve mortality prediction but are difficult to routinely and 
reliably auto-extract from the EHR.  
Conclusion: 
We developed a novel and accurate in-hospital mortality score that was deployed in a live EHR and 
automatically and continuously calculated for real-time evaluation of patient mortality. The score can be 
tuned to a local population and updated to reflect emerging knowledge regarding COVID-19. Moreover, 
this score adheres to the ethical principles necessary for triaging.
37–40
 Further research to test multi-
center score performance, refine mortality prediction over longer periods of time, and investigate the 
optimal methods to use such a score in a CSC protocol is needed. 
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Table 1: Prospective Cohort Characteristics and Hospital Course   
 All Encounters 
(N = 27,296) 
COVID-19 Negative  
(N = 25,938) 
COVID-19 Positive  
(N = 1,358) 
P-value 
Age (SD) 54.3 (20.4) 54.2 (20.5) 56.8 (18.4) P < 0.001 
Female 15,660 (57.4%) 15,057 (58.0%) 603 (44.4%) P < 0.001 
Race    P < 0.001 
  White or Caucasian 20,430 (74.8%) 19,848 (76.5%) 582 (42.9%)  
  Black or African     
      American 
1,964 (7.2%) 1,790 (6.9%) 174 (12.8%)  
  Other 4,481 (16.4%) 3,901 (15.0%) 580 (42.7%)  
  Unknown 421 (1.5%) 399 (1.5%) 22 (1.6%)  
Ethnicity    P < 0.001 
  Non-Hispanic 22,496 (82.4%) 21,755 (83.9%) 741 (54.6%)  
  Hispanic 4,398 (16.1%) 3,795 (14.6%) 603 (44.4%)  
  Unknown 402 (1.5%) 388 (1.5%) 14 (1.0%)  
     
Supplemental O2 16,052 (58.8%) 14,859 (57.3%) 1,193 (87.8%) P < 0.001 
High Flow Nasal  
  Cannula 
1,398 (5.1%) 1,057 (4.1%) 341 (25.1%) P < 0.001 
Non-Invasive     
  Ventilation 
1,482 (5.4%) 1,382 (5.3%) 100 (7.4%) P < 0.001 
     
Median Hospital Days  
  (IQR) 
3.0 (2.0, 5.2) 3.0 (1.9, 5.0) 5.5 (3.0, 9.6) P < 0.001 
Overall Mortality 717 (2.6%) 551 (2.1%) 166 (12.2%) P < 0.001 
     
All Mechanical    
Ventilation 
1,480 (5.4%) 1,241 (4.8%) 239 (17.6%) P < 0.001 
  Median Hospital 
      Days (IQR) 
8.4 (4.6, 15.1) 7.7 (4.1, 13.3) 15.2 (8.2, 21.0) P < 0.001 
  Median ICU Days 
      (IQR) 
3.6 (1.6, 7.8) 2.9 (1.4, 6.2) 9.1 (5.3, 15.0) P < 0.001 
  Median Ventilator 
      Days (IQR) 
1.8 (0.7, 5.7) 1.4 (0.6, 3.9) 7.5 (4.5, 12.6) P < 0.001 
  Mortality 408 (27.6%) 325 (26.2%) 83 (34.7%) P = 0.009 
Reported p-values are to assess differences between COVID-19 Negative and COVID-19 Positive 
encounters. 
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Table 2: Mortality Model Inputs 
 All Encounters 
(N = 27,296) 
COVID-19 Negative  
(N = 25,938) 
COVID-19 Positive  
(N = 1,358) 
P-value 
Scores     
  Median qSOFA (IQR) 0.0 (0.0, 1.0) 0.0 (0.0, 1.0) 0.1 (0.0, 1.0) P < 0.001 
  Median SOFA (IQR) 2.0 (2.0, 4.0) 2.0 (2.0, 3.0) 3.0 (2.0, 5.0) P < 0.001 
  Median CURB-65 (IQR) 1.0 (0.1, 2.0) 1.0 (0.1, 2.0) 1.0 (0.0, 2.0) P = 0.44 
  Charlson Comorbidity                    
         Index (IQR) 
1.0 (0.0, 3.0) 1.0 (0.0, 3.0) 1.0 (0.0, 2.0) P = 0.38 
ARDS Mortality Model     
  Transfusion FFP 59 (0.2%) 59 (0.2%) 0 (0.0%) P = 0.14 
  Transfusion PRBC 396 (1.5%) 392 (1.5%) 4 (0.3%) P < 0.001 
  GCS ≤ 8 264 (1.0%) 246 (0.9%) 18 (1.3%) P = 0.21 
  Lactate > 2 2,676 (9.8%) 2,503 (9.6%) 173 (12.7%) P < 0.001 
  Creatinine ≥ 2 2,486 (9.1%) 2,323 (9.0%) 163 (12.0%) P < 0.001 
  Mean Bilirubin (SD) 0.7 ± 2.0 0.7 ± 2.0 0.6 ± 0.8 P = 0.003 
  Mean Arterial pH (SD) 7.4 ± 0.0 7.4 ± 0.0 7.4 ± 0.1 P = 0.001 
  Mean PF (SD) 335.7 ± 212.7 340.7 ± 215.8 239.6 ± 102.0 P < 0.001 
  Mean SpO2 (SD) 94.7 ± 2.4 94.7 ± 2.4 93.4 ± 3.1 P < 0.001 
Novel Predictors     
  Mean D-Dimer (SD) 405.0 ± 3,699.8 326.4 ± 2,440.3 1,906.2 ± 12,614.9 P < 0.001 
  Mean LDH (SD) 229.1 ± 214.9 223.1 ± 207.4 343.5 ± 305.5 P < 0.001 
  Mean ALC (SD) 1.4 ± 2.0 1.5 ± 2.0 1.3 ± 1.6 P = 0.001 
  Mean BUN (SD) 19.4 ± 15.1 19.3 ± 14.9 21.2 ± 18.4 P < 0.001 
  Mean Troponin (SD) 0.5 ± 9.0 0.6 ± 9.2 0.2 ± 3.9 P = 0.002 
  Mean CK (SD) 173.7 ± 1,612.7 170.5 ± 1,567.2 235.4 ± 2,316.0 P = 0.31 
  Mean ALT (SD) 21.1 ± 20.6 21.1 ± 21.0 20.9 ± 10.4 P = 0.47 
  Mean Lactate (SD) 1.0 ± 1.1 1.0 ± 1.1 1.2 ± 1.6 P < 0.001 
The covariates included in the stacked model are calculated at a single point int time - the time of 
maximum SOFA score for each encounter. Presented are the summary statistics for all patients at that 
single point in time. FFP: fresh frozen plasm, PRBC: packed red blood cells, GCS: Glasgow comas score, 
PF: PaO2 to FiO2 ratio, LDH: lactate dehydrogenase, ALC: absolute lymphocyte count, BUN: blood urea 
nitrogen, CK: creatinine kinase, ALT: alanine aminotransferase 
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Table 3: Model Area under the Receiver Operator Curve  
  Retrospective Validation 
Cohort 
(N = 16,418) 
Prospective 
Validation Cohort 
(N = 27,296) 
COVID-19 Positive 
Validation Cohort 
(N = 1,358) 
SOFA 0.90 0.90 0.85 
qSOFA 0.83 0.84 0.79 
CURB-65 0.81 0.87 0.90 
ARDS Mortality 0.85 0.88 0.86 
Charlson Comorbidity Index 0.63 0.72 0.75 
Novel Variables 0.83 0.88 0.91 
Stacked Model 0.93 0.94 0.90 
The AUROC for each of the component models and the final stacked model. Models were trained and 
validated on the initial retrospective cohort. The models were then validated on the prospective cohort 
and on the subset of patients with COVID-19.  The AUROC for the retrospective cohort is based on a 20% 
holdout of the encounters for testing and evaluation. The prospective validation cohort reflects 
expected performance when running in a live EHR for both COVID-19 positive and negative patients. 
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Figure 1: Study Data Flow: a) Data flow through the EHR and research team, b) Retrospective Cohort 
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Figure 2: Stacked Model AUROC in the Retrospective and Prospective Cohorts: The retrospective 
cohort was used for training and validation (in a 40%-40%-20% split). The prospective and COVID-19 
positive cohorts were used to validate the retrospectively trained model. 
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